Facile fabrication of hypercrosslinked microporous polymer nanospheres for effective inhibition of triple negative breast cancer cells proliferation
Authors:
- 28 March 2022
- journal article
- research article
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 620, 94-106
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21975086, 81872154)
- Ministry of Science and Technology of the People's Republic of China
- Department of Science and Technology, Hubei Provincial People's Government (2018AAA057, 2019CFA008)
- International Science and Technology Cooperation Programme (2018YFE010498)
This publication has 51 references indexed in Scilit:
- Preparation of pyrenyl-based multifunctional nanocomposites for biomedical applicationsNature Protocols, 2016
- FRET-trackable biodegradable HPMA copolymer-epirubicin conjugates for ovarian carcinoma therapyJournal of Controlled Release, 2015
- Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancerBiomaterials, 2015
- Physisorption of gases, with special reference to the evaluation of surface area and pore size distribution (IUPAC Technical Report)Pure and Applied Chemistry, 2015
- Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cellsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Magnetic microporous polymer nanoparticlesPolymer Chemistry, 2012
- Morphology-controlled synthesis of porous polymer nanospheres for gas absorption and bioimaging applicationsJournal of Materials Chemistry, 2012
- Programmable DNA switch for bioresponsive controlled releaseJournal of Materials Chemistry, 2011
- Role of Cationic Group Structure in Membrane Binding and Disruption by Amphiphilic CopolymersThe Journal of Physical Chemistry B, 2010
- Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in miceCancer Gene Therapy, 2005